MedPath

The efficacy of Black seed spray in the treatment of Nasal allergic inflammatio

Phase 2
Recruiting
Conditions
Allergic rhinitis.
Allergic rhinitis, unspecified
J30.4
Registration Number
IRCT20220411054489N1
Lead Sponsor
Babol University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
50
Inclusion Criteria

Children 3-15 years with allergic rhinitis
No consumption of steroids, antihistamines and decongestants during 2 weeks before the study

Exclusion Criteria

Patients with chronic lung diseases other than allergic rhinitis
Heart disease
Kidney disease
Metabolic disorders
Malnutrition patients
Previous allergy to black seed

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
IgE of serum and nasal secretion. Timepoint: At first and one month later. Method of measurement: Laboratory test.;Eosinophil count of serum and nasal secretion. Timepoint: At first and one month later. Method of measurement: Laboratory test.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath